Skip to main content
Table of Contents
Print

What side effects of ADHD medications impact memory? 

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

People with ADHD often wonder whether their medication could make memory worse, especially if they experience forgetfulness or mental fog after starting treatment. In reality, most research shows that ADHD medications usually improve attention, memory and executive function. According to NICE guidance (NG87), stimulant medicines such as methylphenidate and lisdexamfetamine, and the non-stimulant atomoxetine, work by balancing dopamine and noradrenaline in the brain. These chemicals are essential for maintaining focus, motivation and mental clarity. 

The NHS methylphenidate information page confirms that impaired memory is not a recognised side effect. However, some people may experience tiredness, poor sleep or anxiety, which can indirectly affect concentration and recall. NICE also highlights that untreated ADHD itself often causes forgetfulness and distractibility, so effective medication tends to enhance memory rather than reduce it. 

When individuals notice “brain fog,” it is usually temporary and linked to factors such as dose timing, sleep loss or rebound effects as medication wears off. These issues can often be managed through dose adjustments and regular medication reviews with a prescribing clinician. 

Evidence from recent research 

Scientific research consistently shows that ADHD medications support rather than harm cognitive performance. Both stimulant and non-stimulant medicines have been found to improve working memory, attention and processing speed. The degree of improvement varies, but studies indicate clear benefits when treatment is used correctly and monitored carefully. 

How stimulants affect memory and attention 

Stimulant medications are among the most studied treatments for ADHD. A 2024 meta-analysis published in Neuroscience & Biobehavioural Reviews reported that long-term methylphenidate use improved working memory, attention and reaction time in adolescents and adults. Similarly, a King’s College London study found that methylphenidate enhanced spatial working memory and cognitive flexibility in children with ADHD. 

These findings suggest that stimulants help the brain work more efficiently, particularly in areas linked with focus and memory control. When side effects like restlessness or insomnia occur, they can make memory lapses feel more noticeable, but adjusting the dose or timing usually resolves these effects. 

Non-stimulant medications and cognition 

Non-stimulant options such as atomoxetine also improve focus and mental organisation. A randomised controlled trial published in the International Journal of Neuropsychopharmacology found that adults treated with atomoxetine experienced measurable improvements in short-term and working memory. Although stimulants tend to have stronger effects on processing speed, atomoxetine may be more suitable for individuals who experience anxiety or disrupted sleep with stimulant use. 

The most recent NICE review in 2025 confirmed that both types of medication are effective in supporting concentration and learning, with no evidence that they cause memory impairment. 

Why some people experience “brain fog” 

Reports of “mental fog” are usually linked to lifestyle or dosing factors rather than medication toxicity. Rebound symptoms, which can appear as medication wears off, may cause temporary mental fatigue or reduced alertness. The Royal College of Psychiatrists’ ADHD guidance recommends regular medication reviews, along with practical steps such as consistent sleep, hydration and nutrition, to support optimal cognitive performance. 

Key takeaway 

ADHD medications are intended to enhance cognitive performance, not impair it. When forgetfulness or “brain fog” occurs, it is usually the result of tiredness, stress or dose timing rather than the medication itself. Regular follow-up with a qualified clinician, whether through NHS care or private providers such as ADHD Certify, helps ensure treatment remains safe, effective and supportive of clear, consistent thinking. 

Harriet Winslow, BSc
Harriet Winslow, BSc
Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories